Introduction {#sec1-1}
============

Viet Nam, the second most crowded nation positioned in South East Asia, is economically classified as a developing country in the world. Ho Chi Minh city is the largest city located in the south of the country with nearly 10 million people living there, of whom about 20-25% were under 15-year-old with the male to female ratio at birth is 1.122 \[[@ref1]\], \[[@ref2]\]. Intra-axial cranial tumours are the second commonest neoplasm following leukaemia in children occurring in 2.4 to 4 per 100,000 people. In children, primary intra-axial supratentorial brain tumours account for 30-40% \[[@ref3]\]. Whereas, infratentorial brain tumours occupy approximately 60 -- 70% of all brain tumours \[[@ref4]\].

In a previous study, the result showed that the incidence of brain cancer in Vietnam is 2.2 per 100000 for male and 1.4 per 100000 for female. Meanwhile, the percentage of brain cancer in male and female children was 18.1% and 17.2%, respectively \[[@ref1]\]. In reports issued by Central Brain Tumor Registry of the United States, the findings revealed that brain tumours have an incidence of 5.47 per 100,000 children under 14-year-old. It is critical that the most common tumours, leading the cause of cancer-related death were posterior fossa brain tumours (medulloblastomas, ependymomas, and pilocytic astrocytomas) \[[@ref5]\], \[[@ref6]\], \[[@ref7]\], \[[@ref8]\].

The incidence of pediatric brain tumours in Vietnam is lower than that of other countries due to some following reasons \[[@ref2]\]. Vietnamese radiology was legitimately established after Victory Dien Bien Phu by 1954, which was the end of the war against French invasion. Then, Vietnam was suffered from the war against the United States until 1975. Thus, radiology has just developed for nearly 45 years. Even though MRI nowadays plays an important role in the evaluation of brain tumours for appropriate diagnosis, treatment planning and follow-up, approximately 80% of the Vietnamese cities and central hospitals owned only 51 magnetic resonance imaging (MRI) systems by 2009 \[[@ref9]\].

Therefore, it is an apparent fact that there was an under-assessment brain tumour for children in Vietnam due to the insufficiency of non-invasive and innovative MRI modality \[[@ref2]\]. Also, there are only nine hospitals in Vietnam where the appropriate evaluation and surgery for patients with brain tumours can be carried out efficaciously (4 in Ha Noi, 1 in Da Nang and 4 in Ho Chi Minh city) \[[@ref10]\]. Currently, there is no systematic MRI study about pediatric posterior fossa brain tumours in Vietnam. Hence, in this study, we aimed to assess the MRI features of common posterior fossa brain tumours in children including medulloblastomas, ependymomas and pilocytic astrocytomas along with the postoperative parameters to contribute the local knowledge to the neuroradiology and neurosurgery fields.

Material and Methods {#sec1-2}
====================

Ethical consideration {#sec2-1}
---------------------

Institutional Review Board of Children's Hospital 02 approved this retrospective study (745 / ND2-CDT).

Patient population {#sec2-2}
------------------

The study was carried out in the Department of Radiology and Department of Neurosurgery, Children's Hospital 02 from January 2016 to June 2019. In this research, all pediatric patients adopted MRI to evaluate the tumours' characteristics before treatment. Then, patients underwent surgery to eradicate the posterior fossa tumours. Histopathological samples were analysed by histopathologist who had 8-year experience in interpreting brain tumours.

MRI protocol {#sec2-3}
------------

Before 2019, MRI 1.5T scanners were utilised (Essenza, Siemens, Erlangen, Germany and Optima, GE Healthcare, Milwaukee, The United States of America). By 2019, Scanning was additionally performed by 1.5T Multiva, Philips Medical Systems, Best, the Netherlands. All MRI images were interpreted by two certificated MRI radiologists (NMD and MTLB) with over 10-year experience. It is noted that MRI protocols were the same and fully approved by both radiology and neurosurgery departments including non-contrast sagittal T1-weighted imaging (T1W); axial T2-weighted imaging (T2W), coronal T2-Fluid-Attenuated Inversion Recovery (FLAIR), axial gradient-recalled echo T2\*WI, axial Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) and axial T1-weighted with contrast enhancement (CE) (T1CE) (0.1 ml/kg-Gadovist, Bayer, Germany or 0.2ml/kg-Dotarem, Guerbet, France).

Parameters {#sec2-4}
----------

Baseline parameters included the age, sex, symptoms, tumour location, tumour diameters (anterior-posterior (AP); right-left (RL); and feet-head (FH)), tumour characteristics (main structure, components, dilated ventricle, peritumoral oedema, and tumour extension). MRI parameters were comprised of signal intensity (SI) of T1W, T2W, FLAIR, DWI, ADC, and T1CE.

Postoperative parameters included tumour histology, estimated blood loss, surgical time, time at intensive care unit, and total hospital admission time.

Data collection and Statistics {#sec2-5}
------------------------------

Data were collected and stored on a spreadsheet (Excel 2010; Microsoft, Redmond, Washington). Data were analysed by SPSS version 23 (IBM, Armonk, New York). Continuous variables were introduced as mean ± standard deviation and range meanwhile nominal variables were presented as percentage or number of cases. Nominal variables were compared by performing Fisher's exact test. Continuous variables were compared by exploiting the Anova with or without Post-Hoc test if appropriate. Pearson correlation test is used to investigate the relationship between two continuous variables. The observed differences were statistically significant if the p-value was less than 0.05 (p \< 0.05).

Results {#sec1-3}
=======

Baseline parameters {#sec2-6}
-------------------

As shown in [Table 1](#T1){ref-type="table"}, there are 62 pediatric patients (male/female = 1.07/1) with mean age: 6.73 years ± 3.50 (1-15). Medulloblastomas were more dominant in male than in female meanwhile ependymomas and pilocytic astrocytomas were more common in female than in male.

###### 

Baseline characteristics

  Baseline parameters            Overall n = 62          Medulloblastoma n = 27   Ependymoma n = 20       Pilocytic astrocytoma n = 15   P value
  ------------------------------ ----------------------- ------------------------ ----------------------- ------------------------------ ---------------------------------------------------------------------------
  Age (years)                    6.73 ± 3.50 (1-15)      7.79 ± 2.96 (2-15)       4.50 ± 2.85 (1-11)      7.60 ± 3.94 (2-15)             0.002[\*](#t1f1){ref-type="table-fn"}^[α](#t1f2){ref-type="table-fn"}^
  Gender                                                                                                                                 0.019[\*](#t1f1){ref-type="table-fn"}^[β](#t1f3){ref-type="table-fn"}^
   Female                        30 (48.4%)              8                        11                      11                             
   Male                          32 (51.6%)              19                       9                       4                              
  Symptoms                                                                                                                               0.201
   Headache                      33 (53.2%)              14                       10                      9                              
   Vomiting                      13 (21%)                10                       2                       1                              
   Muscle weakness               6 (9.7%)                1                        3                       2                              
   Ataxia                        3 (4.8%)                1                        1                       1                              
   Unconsciousness               3 (4.8%)                1                        2                       0                              
   Epilepsy                      1 (1.6%)                0                        1                       0                              
   Faint                         1 (1.6%)                0                        0                       1                              
   Sensory disorder              1 (1.6%)                0                        0                       1                              
   Dysmetria                     1 (1.6%)                0                        1                       0                              
  Location                                                                                                                               \< 0.001[\*](#t1f1){ref-type="table-fn"}^[β](#t1f3){ref-type="table-fn"}^
   Fourth ventricle              41 (66.1%)              21                       19                      1                              
   Vermis                        9 (14.5%)               2                        1                       6                              
   Right cerebellar hemisphere   7 (11.3%)               2                        0                       5                              
   Left cerebellar hemisphere    5 (8.1%)                2                        0                       3                              
  Diameters                                                                                                                              
   RL (mm)                       48.82 ± 11.01 (21-83)   47.81 ± 9.70 (21-62)     45.00 ± 9.72 (25-63)    55.73 ± 12.29 (32-83)          0.012[\*](#t1f1){ref-type="table-fn"}^[α](#t1f2){ref-type="table-fn"}^
   AP (mm)                       45.69 ± 11.67 (17-67)   44.07 ± 10.70 (20-67)    41.75 ± 10.04 (17-55)   53.83 ± 12.01 (25-67)          0.005[\*](#t1f1){ref-type="table-fn"}^[α](#t1f2){ref-type="table-fn"}^
   FH (mm)                       46.63 ± 11.45 (16-68)   44.41 ± 9.98 (17-63)     46.00 ± 13.82 (16-68)   51.47 ± 9.54 (30-65)           0.153
  Main structure                                                                                                                         \< 0.001[\*](#t1f1){ref-type="table-fn"}^[β](#t1f3){ref-type="table-fn"}^
   Solid                         37 (59.7%)              22                       14                      1                              
   Mixed                         15 (24.2%)              5                        6                       4                              
   Cyst                          10 (16.1%)              0                        0                       10                             
  Components                                                                                                                             \< 0.001[\*](#t1f1){ref-type="table-fn"}^[β](#t1f3){ref-type="table-fn"}^
   Cyst inside tumor             18 (29.0%)              1                        2                       15                             
   Necrosis                      17 (27.4%)              10                       7                       0                              
   Hemorrhage                    8 (12.9%)               6                        2                       0                              
   Calcification                 2 (3.2%)                1                        1                       0                              
  Peritumoral edema              21 (33.9%)              12                       5                       4                              0.302
  Dilated ventricle              55 (88.7%)              25                       17                      13                             0.689
  Tumor extension                                                                                                                        0.016[\*](#t1f1){ref-type="table-fn"}^[β](#t1f3){ref-type="table-fn"}^
   Magendie foramina             7 (11.3%)               2                        5                       0                              
   Left Luschka foramina         4 (6.5%)                1                        3                       0                              
   Right Luschka foramina        3 (4.8%)                0                        2                       1                              
   Both Luschka foramina         2 (3.2%)                0                        2                       0                              
   Sylvius aqueduct              2 (3.2%)                1                        1                       0                              

Statistically significant;

Anova test;

Fisher's exact test.

The mean age of ependymoma was significantly lower than the two other types (p \< 0.05). Two most common locations of tumours were fourth ventricle and vermis. The means of three diameters (AP, RL, and FH) of pilocytic astrocytomas were higher than those of two other types. The main structure of medulloblastomas and ependymomas was predominantly solid whereas the main structure of pilocytic astrocytomas was superiorly cystic (p \< 0.05).

Necrosis and haemorrhage were observed more commonly in medulloblastomas and ependymomas; meanwhile, pilocytic astrocytomas mostly contains cyst inside the tumours (p \< 0.05). Peritumoral oedema was significantly higher in patients with medulloblastomas than in two other types (p \< 0.05). Ependymomas tended to extend tumours through foramina of Luschka and Magendie (p \< 0.05).

MRI parameters {#sec2-7}
--------------

As shown in [Table 2](#T2){ref-type="table"}, medulloblastomas chiefly showed isointense on T2W and FLAIR images meanwhile ependymomas, and pilocytic astrocytomas predominantly appeared hyperintensity on T2W and FLAIR images. Medulloblastomas and ependymomas were mostly high intensity on DWI, and low intensity on ADC whereas pilocytic astrocytomas were usually low intensity on DWI and high intensity on ADC. After injecting CE, pilocytic astrocytomas showed a mixed intensity whereas the signal intensity of medulloblastomas and ependymomas on T1CE was generally strong.

###### 

MRI characteristics

  MRI parameters   Overall n = 62   Medulloblastoma n = 27   Ependymoma n = 20   Pilocytic astrocytoma n = 15   p
  ---------------- ---------------- ------------------------ ------------------- ------------------------------ ---------------------------------------------------------------------------
  T1W                                                                                                           0.474
   Hypointense     58 (93.5%)       25                       18                  15                             
   Mixed           4 (6.5%)         2                        2                   0                              
  T2W                                                                                                           \< 0.001[\*](#t2f1){ref-type="table-fn"}^[β](#t2f2){ref-type="table-fn"}^
   Hyperintense    45 (72.6%)       10                       20                  15                             
   Isointense      15 (24.2%)       15                       0                   0                              
   Mixed           2 (3.2%)         2                        0                   0                              
  FLAIR                                                                                                         \< 0.001[\*](#t2f1){ref-type="table-fn"}^[β](#t2f2){ref-type="table-fn"}^
   Hyperintense    27 (43.5%)       7                        14                  6                              
   Isointense      17 (27.4%)       16                       1                   0                              
   Mixed           13 (21%)         4                        5                   4                              
   Hypointense     5 (8.1%)         0                        0                   5                              
  DWI                                                                                                           \< 0.001[\*](#t2f1){ref-type="table-fn"}^[β](#t2f2){ref-type="table-fn"}^
   Hyperintense    39 (62.9%)       23                       16                  0                              
   Hypointense     23 (37.1%)       4                        4                   15                             
  ADC                                                                                                           \< 0.001[\*](#t2f1){ref-type="table-fn"}^[β](#t2f2){ref-type="table-fn"}^
   Hypointense     39 (62.9%)       23                       16                  0                              
   Hyperintense    23 (37.1%)       4                        4                   15                             
  T1CE                                                                                                          \< 0.001[\*](#t2f1){ref-type="table-fn"}^[β](#t2f2){ref-type="table-fn"}^
   Strong          35 (56.5%)       20                       14                  1                              
   Mixed           17 (27.4%)       0                        3                   14                             
   Slight          10 (16.1%)       7                        3                   0                              

Statistically significant;

Fisher's exact test.

Postoperative parameters {#sec2-8}
------------------------

As shown in [Table 3](#T3){ref-type="table"}, ANOVA test showed that there was no significant difference among total admission time, estimated blood loss, intensive care unit time and surgical time among three groups. Nonetheless, Post-Hoc test revealed that total hospital admission time and intensive care unit time of patients with medulloblastomas were significantly higher than those of patients with pilocytic astrocytomas (p =0.008 and p = 0.045, respectively).

###### 

Postoperative characteristics

  Postoperative parameters         Overall n = 62            Medulloblastoma n = 27      Ependymoma n = 20          Pilocytic astrocytoma n = 15   p
  -------------------------------- ------------------------- --------------------------- -------------------------- ------------------------------ -------
  Surgical time (hour)             5.0 ± 1.1 (3-7)           5.07 ± 1.11 (3-7)           5.25 ± 1.07 (4-7)          4.47 ± 1.06 (3-6)              0.099
  Blood loss volume (ml)           267.1 ± 173.8 (50-1000)   284.82 ± 193.00 (80-1000)   277.00 ± 152.90 (50-500)   222.00 ± 166.83 (50-700)       0.515
  Intensive care unit time (day)   3.0 ± 1.6 (1-9)           3.29 ± 1.59 (2-8)           3.15 ± 1.76 (2-9)          2.67 ± 1.03 (1-5)              0.108
  Hospital admission time (day)    41.3 ± 22.9 (11-136)      44.96 ± 17.54 (19-98)       44.80 ± 32.13 (11-136)     30.20 ± 12.13 (13-51)          0.096

Correlation test {#sec2-9}
----------------

It is observed that there were weak positive correlations between FH diameter and estimated blood loss (r = 0.289, p \< 0.05, Pearson test); and surgical time (r = 0.312, p \< 0.05, Pearson test). Meanwhile, there was a moderate positive correlation between surgical time and estimated blood loss (r = 0.485, p \< 0.05, Pearson test).

Discussion {#sec1-4}
==========

In this clinical study, we focused only the three most common posterior fossa brain tumours including medulloblastomas, ependymomas, and pilocytic astrocytomas. We observed that there were significant differences between age and gender among these groups. In a previous study, mean ages of medulloblastomas, ependymomas, and pilocytic astrocytomas were 6.2; 4.7; and 6.2, respectively. Moreover, the male to female ratios for medulloblastomas, ependymomas, and pilocytic astrocytomas were 1.3/1; 0.67/1; and 1.12/1 \[[@ref11]\]. Meanwhile, in our study, mean ages for medulloblastomas, ependymomas, and pilocytic astrocytomas were 7.79; 4.50; and 7.60. Furthermore, the male to female ratios for medulloblastomas, ependymomas, and pilocytic astrocytomas in this present study were 2.37/1; 0.82/1; and 0.36/1. In many literature papers, medulloblastomas, accounting for 40% of posterior fossa tumors, more prevailing in male, are usually seen before 7-year-old whereas ependymomas, accounting for approximately 20% of the posterior fossa tumours in children with a slight increase of incidence in boys, have a peak incidence in younger pediatric patients from 3- to 5-year-old \[[@ref12]\], \[[@ref13]\]. On the other hand, pilocytic astrocytomas, making up 30% of posterior fossa tumours, appearing between the ages of 5- to 13-year-old \[[@ref12]\], \[[@ref13]\], \[[@ref14]\], have an equal incidence between girls and boys \[[@ref15]\]. Although there are small discriminations about the mean ages and gender ratio among different studies, the results of our study are in agreement with the epidemiological information \[[@ref11]\], \[[@ref12]\], \[[@ref13]\].

Medulloblastomas and ependymomas, usually predominantly solid tumours, are often positioned on the midline in 75% of cases. Medulloblastomas generally progress in the fourth ventricle from the vermis meanwhile ependymomas mostly grow in the fourth ventricle, both resulting in ventricular obstruction and hydrocephalus \[[@ref13]\], \[[@ref16]\]. Medulloblastomas may hardly expand into the foramina of Magendie or Luschka whereas ependymomas frequently show extension through Magendie and Luschka foramina \[[@ref13]\]. By contrast, pilocytic astrocytomas always situate in cerebellar hemisphere and superiorly have mixed appearance of the cystic tumour with mural portion. They slowly evolve and rarely emerge as a solid tumour \[[@ref13]\]. Due to typical characteristics of solid tumours, necrosis and haemorrhage appear more common in medulloblastomas and ependymomas than pilocytic astrocytomas \[[@ref12]\], \[[@ref17]\]. Also, peritumoral oedema presents more generally in patients with medulloblastomas than two other types because medulloblastomas, the most malignant tumour among three types, are graded as 4. As shown in [Table 1](#T1){ref-type="table"}, our findings of baseline characteristics of three tumour types are absolutely in agreement with previous studies \[[@ref12]\], \[[@ref13]\], \[[@ref15]\], \[[@ref16]\], \[[@ref17]\].

Typically, medulloblastomas are densely packed cells and hyperchromatic nuclei, which will result in hypointensity to isointense on T1W image \[[@ref18]\]. Both hyperintensity on DWI and hypointensity on ADC coexisting with hypointense to isointense T2W are due to high cellularity of the tumour \[[@ref18]\], \[[@ref19]\]. Among three types, medulloblastomas are highly malignant and hypervascular; hence, the tumours absorb contrast agents vigorously. Absence of enhancement is seldom, which is noticed in only 7.5% of the tumours \[[@ref12]\], \[[@ref20]\]. Meanwhile ependymomas, generally manifest hypointense T1W, hyperintense T2W, and iso- to hyper-intense FLAIR. On post-contrast enhancement T1W images, tumours generally demonstrate avid enhancement. There are few tumours manifesting little or absence of post-gadolinium enhancement despite being consisted of solid tissue. DWI shows diminished diffusivity within most of ependymomas also due to high cellularity. It is reported that diffusivity of ependymomas is commonly intermediate between that of medulloblastomas and pilocytic astrocytomas \[[@ref21]\], \[[@ref22]\]. Pilocytic astrocytomas typically appear as a predominant cystic tumour with mural nodule. The cysts of pilocytic astrocytomas are commonly hypointense on T1W and hyperintense on T2W; and FLAIR. In few cases, tumours show hyperintensity on T1W and FLAIR when fluid is highly proteinaceous. Unrestricted diffusion is a typical feature of pilocytic astrocytomas \[[@ref23]\], \[[@ref24]\]. Tumours mainly show mixed enhancement because of central cysts without absorbing contrast agents, while the mural portions tend to enhance homogenously and noticeably \[[@ref12]\]. As shown in [Table 2](#T2){ref-type="table"}, our MRI findings are completely in line with these studies \[[@ref12]\], \[[@ref18]\], \[[@ref19]\], \[[@ref20]\], \[[@ref21]\], \[[@ref22]\], \[[@ref23]\], \[[@ref24]\].

In some previous studies, the findings showed that the two most frequent symptoms were headache and vomiting. Also, hydrocephalus was observed in 78-86.7% of the patients \[[@ref4]\], \[[@ref25]\]. In this present study, two dominant symptoms were also headache and vomiting, and hydrocephalus appeared in 88.7% of patients. The two most common locations of tumours were fourth ventricle and vermis along with the means of three-dimension diameters over 4.5 cm producing intracranial hypertension, ventricular obstruction, and dilated ventricle resulting in these clinical symptoms. Hence, our findings are in agreement with these studies \[[@ref4]\], \[[@ref25]\].

Four parameters related to the treatment (surgical time, estimated blood loss volume, intensive care unit time, and total hospital admission time) were not generally significantly different. Medulloblastomas and ependymomas are predominantly solid, but pilocytic astrocytomas are principally cystic. Thus, the elimination of medulloblastomas and ependymomas will be more complicated than that of pilocytic astrocytomas. Nevertheless, in this present study, the means of three-dimension diameters of pilocytic astrocytomas were over 5 cm and higher than those of medulloblastomas. In a previous study, the findings showed that brain tumours with a diameter of at least 5cm are considered as giant brain tumour which generates difficulties during the surgery \[[@ref25]\]. Thus, there are pros and cons in performing surgery to eradicate the medulloblastomas, ependymomas and pilocytic astrocytomas in this present study leading to generally insignificant differences among those parameters. Nevertheless, Post-Hoc test revealed that total hospital admission time and intensive care unit time of patients with pilocytic astrocytomas were significantly shorter than those of patients with medulloblastomas. This difference is mainly due to medulloblastomas classified as grade-4 more malignant than pilocytic astrocytomas regarded as grade-1 the most benign tumour amongst three tumour types \[[@ref13]\], \[[@ref15]\] ([Table 3](#T3){ref-type="table"}).

In this present study, FH diameter had a positive correlation with estimated blood loss and surgical time. The tumours were predominantly located in the fourth ventricle and vermis (80.6%). Anatomically, the fourth ventricle is rather loose at the centre but very narrow to the above Sylvius aqueduct and below central canal of spinal cord. Therefore, the eradication of tumour tissues at the centre of fourth ventricle will be faster and more efficient than tissue nearby sophisticated structures like Sylvius aqueduct and the top of central canal of spinal cord. It is clear that the higher the diameters are, the bigger the tumours are and surgery of bigger tumours will take more time to complete than smaller tumours. We also noticed a positive correlation between surgical time and estimated blood loss. In addition, when the surgical time gets longer to eradicate as much tumour tissue as possible, the blood loss from the collapse of the supplying vascularity of tumour will enhance. In this study, tumors with strong enhancement reflected that perfusion of tumors is significantly effective. Thus, these results are appropriate.

There are some limitations in this present study. Firstly, it is a retrospective design with a small population size; therefore, we do not have abundant and variant findings. Secondly, due to the limitation of innovatively quantified workstation, it is inclined to qualitative research. Thirdly, we just concentrated on three common types of posterior fossa brain tumours in children. Further studies should be as a prospective design with larger sample size. In addition, we also suggest that further studies will introduce quantitative parameters for more objective findings. Future studies also need to focus more on other types of brain tumours to produce plentiful knowledge for clinicians.

In conclusion, MRI plays a crucial role in demonstrating the features of these tumours for appropriate diagnosis and treatment planning. In practice, based on MRI, each tumour has typical MRI features to help clinician discriminate depended on baseline characteristics and MRI characteristics. Among these tumour types, medulloblastomas are problematic brain tumours and the clinicians should take into consideration in cases of larger feet-to-head diameter of tumour to ensure the efficacy and safety surgery for patients.
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